{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:55:30Z","timestamp":1788587730342,"version":"build-2803163510"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073490","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T17:21:17Z","timestamp":1377883277000},"page":"e73490","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy"],"prefix":"10.1371","volume":"8","author":[{"given":"Christina","family":"Westphal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Spallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Konkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Marko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimunnisa","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"DeGraff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alyce","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Regitz-Zagrosek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl C.","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik N.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Hagen","family":"Schunck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cardiores.2005.06.007","article-title":"Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia\/reperfusion injury revisited","volume":"68","author":"GJ Gross","year":"2005","journal-title":"Cardiovasc Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.05.017","article-title":"Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia\/reperfusion injury","volume":"82","author":"JM Seubert","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1074248409358408","article-title":"Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection","volume":"15","author":"K Nithipatikom","year":"2010","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/01.RES.0000146277.62128.6f","article-title":"Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway","volume":"95","author":"K Nithipatikom","year":"2004","journal-title":"Circ Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1469-7793.1998.777bp.x","article-title":"Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells","volume":"508 (Pt 3)","author":"YF Xiao","year":"1998","journal-title":"J Physiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1124\/mol.104.004150","article-title":"Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2","volume":"66","author":"YF Xiao","year":"2004","journal-title":"Mol Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/mol.107.035881","article-title":"Electrophysiological properties of cardiomyocytes isolated from CYP2J2 transgenic mice","volume":"72","author":"Q Ke","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1113\/jphysiol.2001.012896","article-title":"Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes","volume":"537","author":"T Lu","year":"2001","journal-title":"J Physiol"},{"key":"ref9","first-page":"153","article-title":"Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes","volume":"519 Pt 1","author":"HC Lee","year":"1999","journal-title":"J Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1074\/jbc.272.19.12551","article-title":"Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes","volume":"272","author":"S Wu","year":"1997","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yjmcc.2008.09.711","article-title":"Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model","volume":"46","author":"SN Batchu","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.yjmcc.2006.11.020","article-title":"Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts","volume":"42","author":"GJ Gross","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"H2838","DOI":"10.1152\/ajpheart.00186.2008","article-title":"Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart","volume":"294","author":"GJ Gross","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"H47","DOI":"10.1152\/ajpheart.01084.2008","article-title":"Evidence for role of epoxyeicosatrienoic acids in mediating ischemic preconditioning and postconditioning in dog","volume":"297","author":"GJ Gross","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1440-1681.2010.05464.x","article-title":"Cytochrome P450 2J3\/epoxyeicosatrienoic acids mediate the cardioprotection induced by ischaemic post-conditioning, but not preconditioning, in the rat","volume":"38","author":"GG Yu","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Gross GJ, Baker JE, Moore J, Falck JR, Nithipatikom K (2011) Abdominal Surgical Incision Induces Remote Preconditioning of Trauma (RPCT) via Activation of Bradykinin Receptors (BK2R) and the Cytochrome P450 Epoxygenase Pathway in Canine Hearts. Cardiovasc Drugs Ther.","DOI":"10.1007\/s10557-011-6321-9"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1074\/jbc.271.7.3460","article-title":"Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart","volume":"271","author":"S Wu","year":"1996","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.0000139436.89654.c8","article-title":"Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42\/p44 MAPK pathway","volume":"95","author":"J Seubert","year":"2004","journal-title":"Circ Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.11-188300","article-title":"Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart","volume":"25","author":"ML Edin","year":"2011","journal-title":"Faseb J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.yjmcc.2010.01.009","article-title":"Electrophysiological remodeling in heart failure","volume":"48","author":"Y Wang","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF03091824","article-title":"Longitudinal arrhythmogenic remodelling in a mouse model of longstanding pressure overload","volume":"18","author":"M Boulaksil","year":"2010","journal-title":"Neth Heart J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1067\/mhj.2002.122516","article-title":"QRS duration and mortality in patients with congestive heart failure","volume":"143","author":"S Iuliano","year":"2002","journal-title":"Am Heart J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvn133","article-title":"Remodelling of gap junctions and connexin expression in diseased myocardium","volume":"80","author":"NJ Severs","year":"2008","journal-title":"Cardiovasc Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.RES.88.3.333","article-title":"Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43","volume":"88","author":"DE Gutstein","year":"2001","journal-title":"Circ Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1161\/CIRCRESAHA.111.244046","article-title":"Phosphatase-resistant gap junctions inhibit pathological remodeling and prevent arrhythmias","volume":"108","author":"BF Remo","year":"2011","journal-title":"Circ Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.RES.0000074883.66422.C5","article-title":"Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning","volume":"92","author":"SK Jain","year":"2003","journal-title":"Circ Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"H175","DOI":"10.1152\/ajpheart.01211.2009","article-title":"Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts","volume":"299","author":"JC Quindry","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.RES.0000015328.20581.D6","article-title":"Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid","volume":"90","author":"R Popp","year":"2002","journal-title":"Circ Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1478-3231.2011.02509.x","article-title":"Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats","volume":"31","author":"M Bolognesi","year":"2011","journal-title":"Liver Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJM200104053441407","article-title":"Atrial fibrillation","volume":"344","author":"RH Falk","year":"2001","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","article-title":"Atrial fibrillation pathophysiology: implications for management","volume":"124","author":"YK Iwasaki","year":"2011","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00210-009-0474-0","article-title":"Cardiac adrenergic control and atrial fibrillation","volume":"381","author":"AJ Workman","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"B Burstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-5922.2010.00150.x","article-title":"Soluble Epoxide Hydrolase Inhibitors and Heart Failure","volume":"29","author":"H Qiu","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"D Xu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"J Monti","year":"2008","journal-title":"Nat Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"R1597","DOI":"10.1152\/ajpregu.00825.2009","article-title":"Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload","volume":"298","author":"D Fliegner","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1067\/mje.2002.120202","article-title":"Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography","volume":"15","author":"MA Quinones","year":"2002","journal-title":"J Am Soc Echocardiogr"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/HYPERTENSIONAHA.107.103143","article-title":"Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension","volume":"51","author":"R Fischer","year":"2008","journal-title":"Hypertension"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.HYP.0000091265.94045.C7","article-title":"14,15-epoxyeicosa-5(Z)-enoic-mSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries","volume":"42","author":"KM Gauthier","year":"2003","journal-title":"Hypertension"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T17:16:15Z","timestamp":1563815775000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073490"}},"subtitle":[],"editor":[{"given":"Paula A.","family":"da Costa Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073490","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}